BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Bank of America Maintains Bearish Stance on Hims & Hers Health Despite Year-to-Date Rally
Bank of America Maintains Bearish Stance on Hims & Hers Health Despite Year-to-Date Rally
16
1
BTCCSquare news:
Bank of America Securities analyst Allen Lutz reaffirmed a Sell rating on Hims & Hers Health (HIMS) stock, citing diminished likelihood of a Q3 earnings beat. The telehealth platform's shares have surged over 130% year-to-date, defying regulatory concerns and a fallout with Novo Nordisk over compounded semaglutide allegations.
Revenue growth Optimism persists despite headwinds, with online sales estimates for Q3 ranging between $565 million and $596 million—potentially exceeding consensus. The disconnect between fundamental challenges and market performance underscores the speculative nature of growth-stage healthcare investments.
By:
